Response to Letter to the Editor, Gilks et al

The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

PTCH1 mutations and tumor-agnostic clinical outcomes with hedgehog pathway inhibitors across cancer types.

NPJ precision oncology·2026

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumours.

Histopathology·2026

Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.

Nature communications·2026

Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort study.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Letter to the Editor: Low-energy fractional carbon dioxide laser priming of mesenchymal stem cell-derived exosomes: A photothermal boost for diabetic wound angiogenesis.

World journal of methodology·2026

Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine.

Oncotarget·2026

A Model and Descriptive Case Example for Partnered Implementation Playbook Development.

Global implementation research and applications·2026

Development of latent fingermarks on the surfaces of photo paper.

Journal of forensic sciences·2026

Corrigendum to 'SCAI 2026 Scientific Sessions Abstracts' [Journal of the Society for Cardiovascular Angiography & Interventions 5/4S (2026)].

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Related Experiment Videos

Response to Letter to the Editor, Gilks et al

Related Concept Videos

The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

PTCH1 mutations and tumor-agnostic clinical outcomes with hedgehog pathway inhibitors across cancer types.

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumours.

Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.

Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort study.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Letter to the Editor: Low-energy fractional carbon dioxide laser priming of mesenchymal stem cell-derived exosomes: A photothermal boost for diabetic wound angiogenesis.

Incidence of KRAS G12C mutations in genitourinary malignancies; emerging target in precision medicine.

A Model and Descriptive Case Example for Partnered Implementation Playbook Development.

Development of latent fingermarks on the surfaces of photo paper.

Corrigendum to 'SCAI 2026 Scientific Sessions Abstracts' [Journal of the Society for Cardiovascular Angiography & Interventions 5/4S (2026)].

Related Experiment Videos

Response to Letter to the Editor, Gilks et al

Related Concept Videos

Related Articles